The Role of Early Respiratory Physiotherapy Rehabilitation in the Recovery of a patient with Pleural Empyema - A Case Report
Gauri Bhutada1, Vishnu Vardhan2
1Second-Year MPT Student, Department of Cardiovascular and Respiratory Physiotherapy,
Ravi Nair Physiotherapy College, Datta Meghe Institute of Higher Education and Research,
Sawangi (Meghe), Wardha - 442001.
2Head of the Department, Cardiovascular and Respiratory Physiotherapy Department,
Ravi Nair Physiotherapy College, Datta Meghe Institute of Higher Education and Research,
Sawangi (Meghe), Wardha - 442001.
*Corresponding Author E-mail: gauribhu1998@gmail.com
Abstract:
The Pus in the pleural space is referred to as empyema and is frequently caused by nearby pneumonia, trauma to the chest wall, or a complication following thoracic surgery. Pleural empyema is a serious condition characterized by the accumulation of purulent material in the pleural space, often resulting from bacterial infection. Early intervention and targeted treatment strategies are crucial in managing this condition effectively. This case study describes how early intervention and chest physical therapy helped a 44-year-old patient successfully manage pleural empyema. The patient received early antibiotic medication and chest physiotherapy, which included postural drainage and percussion, for their fever, chest pain, and respiratory distress. This method eliminated the need for more invasive operations by significantly reducing pleural empyema, enhancing lung function, and alleviating symptoms. This case illustrates the effectiveness of combining early medical and physiotherapeutic therapies in improving outcomes for pleural empyema.
KEYWORDS: Pleural Empyema, Chest Physiotherapy, Early Intervention.
INTRODUCTION:
Pleural empyema (PE) is the term for pus in the pleural space, which is frequently brought on by nearby pneumonia, damage to the chest wall, or a post-thoracic surgical problem. It can be managed with a variety of treatment approaches, such as thoracotomy drainage, video-assisted thoracoscopic surgery (VATS), intercostal drainage, and percutaneous aspiration1. In terms of treatment success, surgical debridement or decortication—possibly through video-assisted thoracoscopic surgery (VATS)—has been shown to be superior to tube thoracostomy alone2. About 65 percent of infections are caused by streptococcal species, such as S. aureus and SMG3. It seems that a subset of pleural empyema is caused by a group of bacteria that are not typically thought to be involved in pneumonia4. The presence of bacteria in pleural fluid as determined by Gram stain, culture, or 16S rRNA gene PCR was characterized as PE5. On rare occasions, fluid may accumulate in the spaces between the pleural layers or in the fissures when pleuritis is present (visceral and parietal). The most common things to culture are blood, pus, and exudative fluid6. Histoplasmosis is a primary fungal disease and a granulomatous disease caused by Histoplasma capsulatum. Although distributed worldwide, it is most prevalent in South, Central, and North America.7
Most Histoplasma infections are asymptomatic in normal immune hosts and do not result in long-term adverse sequelae. The remaining infected individuals develop one of several different clinical syndromes. A classification scheme subdivides symptomatic disease into acute pulmonary histoplasmosis, disseminated histoplasmosis, chronic pulmonary histoplasmosis, and complications from an excessive fibrotic response to the body8 Disseminated histoplasmosis occurs primarily in immunocompromised persons, elderly individuals, and patients with underlying chronic diseases.9
Few reports have investigated pleural effusion with Histoplasma, and a small number of acute histoplasmosis cases lead to pleural effusion10. Herein, we report for the first time, to our best knowledge, a case of empyema due to Histoplasma and bacterial infections in a diabetic patient after gastric cancer surgery treated with oral anticancer agents. We also review the literature to highlight the clinical features of this uncommon manifestation of histoplasmosis11. Because of the fluid's plasma protein content, the pleural layers converge and may become adherent, organizing fibrin. Fibrous tissue restricts lung mobility, which ultimately results in a change in the patient's breathing pattern12. The goals of physical therapy are to prevent the development of incapacitating adhesions between two pleural layers, restore lung expansion in its entirety, enhance lung ventilation, increase exercise tolerance, and preserve joint mobility13. In this case, the patient was receiving treatment and rehabilitation in hopes of improving his pleural empyema diagnosis, which was made a few months previously. He was referred to the physical therapy department, where the patient was given a proper, carefully planned treatment plan.
CASE PRESENTATION:
Patient Information:
The patient is a 44-year-old guy with a dominant right hand who initially complained of dyspnoea, a persistent cough with white sputum, and chest pain that lasted for one month. These sensations have gotten worse over time, making it harder to carry out regular tasks and decreasing your range of motion. First, the patient went to a Yavatmal private hospital and was given medicine. Later, Acharya Vinobha Bhave Rural Hospital was recommended to him, where X-rays and other diagnostic tests were performed, leading to a diagnosis of pleural empyema. Following this, he was referred for cardiopulmonary physiotherapy. Written and verbal consent from the patient was taken. On examination, the patient was found lying supine with the head end 30 degrees up. The patient suffered tachypnoea while being observed. He knew the time, where it was, and who all these people were. With a respiratory rate of 26 breaths per minute and an oxygen saturation of 95% on room air, the patient was mesomorphic and afebrile. A chest auscultation demonstrated bilaterally reduced air entry, and lower zones had intentional heard crackles. Chest radiograph revealed a uniform, greyish-white area that obscures the costophrenic angle, and the pleural membranes appear thickened and irregular.
Diagnostic Assessment:
To inspect the condition and severity, radiographic scans were carried out after and before the treatment. The chest X-ray, which reveals pleural empyema pre-treatment (Figure 1) and the chest x-ray of post treatment show positive recovery (Figure 2).
Therapeutic Intervention:
After the patient was made aware of his condition and approval was obtained, the procedure went as planned. A multidisciplinary approach facilitated the patient's faster recovery by increasing air entry throughout treatment. For three weeks, nebulization and aerosol therapy were applied three times a day to improve air circulation. The treatment was effective, based on the outcome measures that were obtained during the evaluation. As a result, the patient received interventions is given in (Table 1).
Table1: Tailored physiotherapy management which was given for one weeks
Goals |
Intervention |
Description of intervention |
Repetition |
Patient education |
Guidance to patient and family members about the condition |
The causes of pleural empyema are explained. The significance of pulmonary rehabilitation in conjunction with medical supervision is discussed. Patient is made aware of the importance of following an exercise program and receiving pulmonary rehabilitation. |
- |
To increase lung ventilation and oxygenation |
Segmental breathing exercises like incentive spirometry and lateral coastal expansion deep breathing |
The patient is instructed to inspire and expire while exhaling physiotherapist applies pressure laterally and downward. |
10 reps x 1 set |
To increase thoracic expansion |
Thoracic expansion exercises |
In order to promote chest expansion, the patient is told to raise their hands during inhalation and lower them during exhalation. |
10 reps x 1 set |
To increase flexibility |
Upper limb and lower limb mobility exercises |
Exercises involving active range of motion was given |
10 reps x 1 set |
To improve endurance |
Spot marching, brisk walking and ambulation around hall. |
In the presence of a physiotherapist, the patient is urged to progress their spot marching exercises to include walking up stairs and around the hall. |
15 min |
Table 2: Advanced pulmonary rehabilitation which was given for two weeks
Goals |
Intervention |
Description of intervention |
Repetition |
Aerobic exercise training |
Arm leg ergometry |
The patient receives instruction on the procedure of the static cycle. He was instructed to cycle till he was exhausted. |
30 min |
To enhance pulmonary function and the strength of the inspiratory muscles. |
Inspiratory muscle training device |
The patient is directed to breathe via the device and inhale as deeply as possible. It is carried out under the guidance of a physiotherapist. |
10 reps x 2sets |
Home program |
Breathing techniques, such as deep breathing techniques. strengthening exercises using a one-litre water bottle for the upper and lower limbs. Inspired spirometry for endurance, walk around. |
To prevent collapse, all workouts are recommended for the home program. |
20 reps x 2 sets |
Follow-up and outcome measure:
The patient was thoroughly assessed before patient rehabilitation, outcome measures were recorded post-rehabilitation, the home program was prescribed for two weeks, and assessment was taken at the time of follow-up (end of the seventh week) which revealed progression. Table 3 shows the outcome measures that were assessed after the completion of advanced pulmonary rehabilitation. The reliability of the six-minute walk test is 0.96 and the validity is 0.88.
Table 3:
Outcome measure |
Pre-physiotherapy intervention |
Post-physiotherapy intervention (5thweek) |
MMRC scale of dyspnea |
Grade II |
Grade I |
Six-minute walk test |
120 m |
300m |
Health-related quality of life (SF-6) |
20 |
55 |
DISCUSSION:
Pus accumulation in the pleural cavity known as an empyema is most frequently brought on by underlying lung conditions such bacterial pneumonia, tuberculosis, lung abscess, or bronchiectasis. Most frequently, direct infection into the pleural space14. When fluid accumulates in the pleural cavity, pleural effusion happens. Either transudation or exudation can cause it. It could have no symptoms or be connected to pleuritic discomfort15. A secondary cause of pleural effusion may be empyema. A physiotherapist can help patients with these diseases by helping them restore mobility and function and by enhancing their quality of life16. A common component of post-thoracoscopy care has traditionally been chest physical therapy17. Thoracic expansion exercises, early mobilization, splinted coughing or huffing, the use of mechanical devices, and a carefully thought-out home exercise regimen upon discharge are all included18. Patients with pleural empyema who additionally receive physiotherapy as part of their routine care have better spirometry and radiological findings as well as shorter hospital stays, according to another study by Valenza-Demet et al.19
Intermittent positive airway pressure allows for optimal lung expansion, which accelerates the removal of pleural effusion, reduces the duration of respiratory system impairment and chest drainage in patients, shortens hospital stays, and lowers the risk of developing pulmonary complications20.
We can, therefore, draw the conclusion that forced vital capacity, functional capacity, and pulmonary function can all be enhanced by using flow-metric incentive spirometry in conjunction with breathing exercises and airway clearing strategies. In order to both prevent and treat lung issues; chest physical therapy is crucial.
CONCLUSION:
This case study shows how the management of pleural empyema can be greatly improved by incorporating chest physical therapy and acting quickly. The patient's symptoms significantly improved, pleural fluid decreased, and general respiratory function improved after receiving targeted antibiotics and physiotherapeutic treatments promptly. The positive result in this instance emphasizes the need for prompt, thorough care in averting problems and avoiding more intrusive operations, which maximizes patient recovery.
REFERENCES:
1. Redden MD, Chin TY, Driel ML van. Surgical versus non‐surgical management for pleural empyema. Cochrane Database Syst Rev [Internet]. 2017 [cited 2024 Aug 26] ;(3). Available from: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010651.pub2/full
2. Scarci M, Abah U, Solli P, Page A, Waller D, van Schil P, et al. EACTS expert consensus statement for surgical management of pleural empyema. Eur J Cardiothorac Surg. 2015 Nov 1;48(5):642–53.
3. Lin J, Zhang Y, Bao C, Lu H, Zhong Y, Huang C, et al. The Clinical Features and Management of Empyema Caused by Streptococcus constellatus. Infect Drug Resist. 2022 Jan 1; 15:6267–77.
4. Dyrhovden R, Nygaard RM, Patel R, Ulvestad E, Kommedal Ø. The bacterial aetiology of pleural empyema. A descriptive and comparative metagenomic study. Clin Microbiol Infect. 2019 Aug 1;25(8):981–6.
5. Prabawa IMY, Silakarma D, Manuaba IBAP, Widnyana M, Jeviana A. Chest therapy and breathing exercise in COVID-19 patient: a case report. Bali Med J. 2021 Jun 13;10(2):495–8.
6. Karkhanis VS, Joshi JM. Pleural effusion: diagnosis, treatment, and management. Open Access Emerg Med OAEM. 2012; 4:31–52.
7. Hage CA, Wheat LJ, Loyd J, Allen SD, Blue D, Knox KS. Pulmonary Histoplasmosis. Semin Respir Crit Care Med. 2008 Apr;29(2):151–65.
8. Valdez AF, Miranda DZ, Guimarães AJ, Nimrichter L, Nosanchuk JD. Pathogenicity & virulence of Histoplasma capsulatum - A multifaceted organism adapted to intracellular environments. Virulence. 2022 Dec;13(1):1900–19.
9. Influence of Zinc on Histoplasma capsulatum Planktonic and Biofilm Cells - PubMed [Internet]. [cited 2024 Aug 29]. Available from: https://pubmed.ncbi.nlm.nih.gov/38786716/
10. Nabet C, Belzunce C, Blanchet D, Abboud P, Djossou F, Carme B, et al. Histoplasma capsulatum causing sinusitis: a case report in French Guiana and review of the literature. BMC Infect Dis. 2018 Nov 26;18(1):595.
11. A Case of Oral Histoplasmosis Concomitant with Pulmonary Tuberculosis - PubMed [Internet]. [cited 2024 Aug 29]. Available from: https://pubmed.ncbi.nlm.nih.gov/31781410/
12. Freeman AF, Ben-Ami T, Shulman ST. Streptococcus pneumoniae empyema necessitatis. Pediatr Infect Dis J. 2004 Feb;23(2):177–9.
13. Pathan A, Yadav V, Jain M, Saifee S. An Early Comprehensive Physiotherapy Approach towards Reconditioning of Patient with Empyema Thoracis: A Case Study. J Pharm Res Int. 2021 Dec 17;108–12.
14. The management of pleural space infections - Chapman - 2004 - Respirology - Wiley Online Library [Internet]. [cited 2024 Aug 29]. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/j.1440-1843.2003.00535.x
15. Pahal P, Rajasurya V, Sharma S. Typical Bacterial Pneumonia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Aug 29]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK534295/
16. Krishna R, Antoine MH, Rudrappa M. Pleural Effusion. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Aug 29]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK448189/
17. Jain MJ, Vardhan V. SARS-CoV-2 atypical viral pneumonia with 25/25 computed tomography score. Pan Afr Med J. 2021; 39:161.
18. IJPOT July-sept 2010.pdf [Internet]. [cited 2024 Aug 29]. Available from: https://ijpot.com/scripts/IJPOT%20July-sept%202010.pdf#page=21
19. Valenza-Demet G, Valenza MC, Cabrera-Martos I, Torres-Sánchez I, Revelles-Moyano F. The effects of a physiotherapy programme on patients with a pleural effusion: a randomized controlled trial. Clin Rehabil. 2014 Nov;28(11):1087–95.
20. da Conceição Dos Santos E, Lunardi AC. Efficacy of the addition of positive airway pressure to conventional chest physiotherapy in resolution of pleural effusion after drainage: protocol for a randomised controlled trial. J Physiother. 2015 Apr;61(2):93.
Received on 31.03.2025 Revised on 18.04.2025 Accepted on 03.05.2025 Published on 15.05.2025 Available online from May 17, 2025 Research J. Science and Tech. 2025; 17(2):115-118. DOI: 10.52711/2349-2988.2025.00016
|
|
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License. |
|